Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation. (Q47688758)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation. (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

author name string

In Soo Oh

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

Tae Wook Kang

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

Min Woo Lee

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

Wonseok Kang

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

Geum-Youn Gwak

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

Yong-Han Paik

7

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

Moon Seok Choi

8

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

Joon Hyeok Lee

9

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

Kwang Cheol Koh

10

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

Seung Woon Paik

11

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

publication date

5 October 2017

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

62

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

3235-3242

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

11

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

https://scigraph.springernature.com/pub.10.1007/s10620-017-4775-8

0 references

Ablation of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Small single-nodule hepatocellular carcinoma: comparison of transarterial chemoembolization, radiofrequency ablation, and hepatic resection by using inverse probability weighting.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Assessment of prognosis of cirrhosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

The albumin-bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug development.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

[Practice guidelines for management of hepatocellular carcinoma 2009].

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Prognostic significance of combined albumin-bilirubin and tumor-node-metastasis staging system in patients who underwent hepatic resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Post hepatectomy liver failure: concept of management

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection--Propensity Score Analyses of Long-term Outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

Personalized treatment of patients with very early hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4775-8

21 January 2018

2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/28983724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Practice guideline for diagnosis and treatment of hepatocellular carcinoma].

1 reference

https://pubmed.ncbi.nlm.nih.gov/28983724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-017-4775-8

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/28983724

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47688758&oldid=1465442926"